Cancers that occur in each part of the uterus have their own names, such as cervical cancer or endometrial cancer, but are sometimes broadly defined as uterine cancer because the structure is part of the uterus. If you have uterine or endometrial cancer, you want the care that will give you the best chance for recovery. Fortunately, you’ll find it right here, close to home. A fellowship-trained gynecologic oncologist is the best type of doctor to treat uterine cancer. But there are only about 600 of these specialists in the nation. We have gynecologic oncologists as part of the Lehigh Valley Cancer Institute. They provide you with the most advanced care, including access to treatments that aren’t available elsewhere. You’ll receive superior medical care and practical help for you and your family during treatment and recovery.
We use a multidisciplinary team approach to uterine cancer. That means whether you’re being diagnosed for the first time or looking for a second opinion, you will meet with our Gynecologic Cancer Multidisciplinary Consultation Program (Gynecologic MDC) team, which includes a gynecologic oncologist, medical oncologist, radiation oncologist and patient navigator. You will see the entire team of specialists in the same day. Team members will review every aspect of your case and offer the best treatment recommendation – this approach is most effective in aggressively and successfully treating cancer. You also will be connected to a caring support team that includes financial counselors, social workers and others who will be available to you throughout your cancer journey.
The Lehigh Valley Cancer Institute is a member of the Memorial Sloan Kettering Cancer Alliance, which gives you access to groundbreaking, lifesaving cancer care and breakthrough clinical research right here in the Lehigh Valley. LVHN patients have access to MSK clinical trials. This accelerates the data-collection process so investigational treatments can be approved faster and become available to more patients. See the clinical trials currently being conducted at the Lehigh Valley Cancer Institute.